APA (7th ed.) Citation

Phatak, P., Brissot, P., Wurster, M., Adams, P. C., Bonkovsky, H. L., Gross, J., . . . Pietrangelo, A. (2010). A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology, 52(5), . https://doi.org/10.1002/hep.23879

Chicago Style (17th ed.) Citation

Phatak, Pradyumna, et al. "A Phase 1/2, Dose-escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-related Hereditary Hemochromatosis." Hepatology 52, no. 5 (2010). https://doi.org/10.1002/hep.23879.

MLA (9th ed.) Citation

Phatak, Pradyumna, et al. "A Phase 1/2, Dose-escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-related Hereditary Hemochromatosis." Hepatology, vol. 52, no. 5, 2010, https://doi.org/10.1002/hep.23879.